ライフサイエンスコーパス: nuclear medicine

1 valuable for improved diagnostics in routine nuclear medicine.

2 iative backed by the European Association of Nuclear Medicine.

3 of the pivotal role of (99m)Tc in diagnostic nuclear medicine.

4 risk estimation in the context of pediatric nuclear medicine.

5 y in preclinical cancer research but also in nuclear medicine.

6 s for use in both diagnostic and therapeutic nuclear medicine.

7 radiation protection purposes in diagnostic nuclear medicine.

8 those in the fields of medical oncology and nuclear medicine.

9 l SPECT systems have become a major focus in nuclear medicine.

10 y, radiation medicine, medical oncology, and nuclear medicine.

11 argets and thus playing an important role in nuclear medicine.

12 al uptake in both diagnostic and therapeutic nuclear medicine.

13 al imaging studies of cancer in the field of nuclear medicine.

14 n vitro methods is an important challenge in nuclear medicine.

15 e a welcome addition to the armamentarium of nuclear medicine.

16 icients for risk analysis of the patients in nuclear medicine.

17 larity to pertechnetate, both having uses in nuclear medicine.

18 ic phantoms in many clinical applications in nuclear medicine.

19 rently in the spotlight of radiopharmacy and nuclear medicine.

20 n and procedure standardization in pediatric nuclear medicine.

21 ere the those of the European Association of Nuclear Medicine (60%).

22 Initiated by the German Society of Nuclear Medicine, a retrospective multicenter data analy

23 nable dosimetric properties for a diagnostic nuclear medicine agent.

24 rs and represents a shift toward activatable nuclear medicine agents.

25 Two nuclear medicine and 2 genitourinary radiologists indepe

26 c electronics and photonics, drug discovery, nuclear medicine and complex molecule synthesis, because

27 ing continue to evolve with the inclusion of nuclear medicine and in vivo molecular imaging based on

28 of nuclear medicine in 1971, the practice of nuclear medicine and its training programs have undergon

29 nical Trials Network (CTN) of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) operates

30 The Society of Nuclear Medicine and Molecular Imaging and the American

31 d in protocols compliant with the Society of Nuclear Medicine and Molecular Imaging and the European

32 scanner validation program of the Society of Nuclear Medicine and Molecular Imaging Clinical Trials N

33 e Alzheimer's Association and the Society of Nuclear Medicine and Molecular Imaging convened the Amyl

34 er disorders of gastric motility; Society of Nuclear Medicine and Molecular Imaging guidelines are pr

35 g, performed according to current Society of Nuclear Medicine and Molecular Imaging guidelines, serve

36 the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging previously publis

37 ped by the RADAR committee of the Society of Nuclear Medicine and Molecular Imaging, based on 2007 re

38 dicine departments (n = 13, 33%), jointly by nuclear medicine and radiology (n = 11, 28%), and radiol

39 his study were to evaluate trained readers' (nuclear medicine and radiology physicians) visual assess

40 n of knowledge and technological advances in nuclear medicine and radiology require physicians to hav

41 changes have unmasked weaknesses in current nuclear medicine and radiology training programs.

42 manner consistent with the needs of both the nuclear medicine and the radiation protection communitie

43 ultrasonography, magnetic resonance imaging, nuclear medicine, and genomic techniques, such as real-t

44 journals in the subject category "radiology, nuclear medicine, and medical imaging" at the Institute

45 ial utility to the fields of radiochemistry, nuclear medicine, and molecular imaging.

46 nuclear reactors created the opportunity for nuclear medicine, and one of the co-inventors of MRI was

47 pe, whether the hospital practices pediatric nuclear medicine, and the hospital's method for determin

48 merican College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomog

49 ties can be used, including ultrasonography, nuclear medicine, and the traditionally used techniques

50 aphy [CT], magnetic resonance imaging [MRI], nuclear medicine, and ultrasound).

51 nance imaging, interventional radiology, and nuclear medicine; and (c) discuss the problems radiology

52 ents who may have been discouraged without a nuclear medicine approach.

53 electrodes placed under CT guidance, several nuclear medicine approaches with imaging agents that acc

54 ar imaging heightens the promise of clinical nuclear medicine as a tool for individualization of pati

55 In this way, the full potential of nuclear medicine as an effective and efficient tool for

56 sought to describe the practice of pediatric nuclear medicine at general hospitals in the United Stat

57 spective to the available radiologic- and/or nuclear medicine-based imaging technologies.

58 ude mammography, MR imaging, ultrasound, and nuclear medicine-based methods such as (99m)Tc-sestamibi

59 omplement the routinely used radiologic- and nuclear medicine-based modalities.

60 ng with three-dimensional radiologic- and/or nuclear medicine-based preinterventional imaging may ove

61 ployment prospects for physicians trained in nuclear medicine but not also trained in diagnostic radi

62 -99m, the most commonly used radionuclide in nuclear medicine, can be attached to biologically import

63 nowadays the widely used echocardiographic, nuclear medicine, cardiac computed tomographic (CT), and

64 o data published regarding the proportion of nuclear medicine centers using SPECT or SPECT/CT rather

65 (NSCLC) patients, we investigated whether 18 nuclear medicine centers would score tracer uptake inten

66 At three tertiary nuclear medicine centres, we used whole body planar imag

67 sufficient pool of incoming highly qualified nuclear medicine clinicians.

68 Our aim was to investigate how far the nuclear medicine community has come on its way from accu

69 The nuclear medicine community should develop pediatric stan

70 rce code would be a welcome resource for the nuclear medicine community.

71 radiolabeled drugs, metabolic precursors and nuclear medicine contrast agents) by single cells withou

72 this background, the ACR and the Society of Nuclear Medicine convened the Task Force on Nuclear Medi

73 were heterogeneous (European Association of Nuclear Medicine criteria, 35%; Prospective Investigatio

74 most physiologically based quantification of nuclear medicine data.

75 the dose rate from NET patients exiting the nuclear medicine department after undergoing PET/CT with

76 Any nuclear medicine department equipped with a modern hybri

77 Thus, when exiting the nuclear medicine department, the NET patients injected w

78 Systems were primarily operated by nuclear medicine departments (n = 13, 33%), jointly by n

79 lability of (99m)Tc has become a concern for nuclear medicine departments across the globe.

80 ion to the special needs of this population, nuclear medicine departments can successfully study pati

81 The between-center agreement (18 nuclear medicine departments connected with a dedicated

82 multiple-choice questions was distributed to nuclear medicine departments in Australia, Canada, and F

83 ion program from the European Association of Nuclear Medicine (EANM) (PSFEARL).

84 ular Imaging and the European Association of Nuclear Medicine (EANM) acquisition guidelines and were

85 stered doses and the European Association of Nuclear Medicine (EANM) Dosage Card guidelines recommend

86 ions increased by an average of 7% per year, nuclear medicine examinations by 12% per year, and compu

87 le patient's dose accumulation from multiple nuclear medicine examinations was created.

88 ional radiologic examinations and 18 million nuclear medicine examinations were performed.

89 diologic, 0.5 billion dental, and 37 million nuclear medicine examinations) are performed annually.

90 data on dosimetry practices for 16 pediatric nuclear medicine examinations, including the minimum tot

91 r CT, and 0.40 mGy (range, 0.01-7.7 mGy) for nuclear medicine examinations.

92 ional workshop attended by hematologists and nuclear medicine experts in Deauville, France, proposed

93 ion SPECT studies is comparable with that of nuclear medicine experts in detecting and locating CAD.

94 were reviewed by an international panel of 6 nuclear medicine experts using the 5-point score.

95 showing only moderate reproducibility among nuclear medicine experts, indicate the need to standardi

96 can be used for SLN biopsy in settings where nuclear medicine facilities are not available, albeit wi

97 entifying structures and patterns present in nuclear medicine flood-field uniformity images.

98 is an artificial beta emitter widely used in nuclear medicine for diagnostic tests.

99 ostics has been used in clinical routines in nuclear medicine for more than 60 y-as (131)I for diagno

100 ics, is among the most promising concepts in nuclear medicine for optimizing and individualizing trea

101 adjunctive nonradioactive pharmaceuticals in nuclear medicine from 2007 to 2011.

102 Pediatric patients are referred to nuclear medicine from nearly all pediatric specialties i

103 rallel-hole collimator mounted to a standard nuclear medicine gamma-camera as a function of distance

104 American College of Radiology and Society of Nuclear Medicine guidelines.

105 r imaging data acquired in the department of nuclear medicine guides the surgical management of patie

106 fferences existed, all subspecialties except nuclear medicine had significantly more high-visibility

107 Nuclear medicine has an important role in the care of ne

108 Nuclear medicine has been at the forefront of molecular

109 Nuclear medicine has been largely a diagnostic specialty

110 nd, specifically, alpha-particle emitters in nuclear medicine has brought to the forefront the need f

111 g and peptide receptor radionuclide therapy, nuclear medicine has earned a major role in gastroentero

112 tion Dose (MIRD) Committee of the Society of Nuclear Medicine has provided a broad framework for asse

113 In particular, nuclear medicine has seen the development of several rad

114 ety of Nuclear Cardiology and the Society of Nuclear Medicine have recognized the role of attenuation

115 In this Journal of Nuclear Medicine Hot Topics discussion, we review the hi

116 Three percent of nuclear medicine images showed alternative findings such

117 e pertechnetate was identified on 38% of the nuclear medicine images.

118 embolization treatment planning makes use of nuclear medicine imaging (NMI) of (99m)Tc-macroaggregate

119 ibitor (EPI-HNE-2) may represent an improved nuclear medicine imaging agent for inflammation and infe

120 ly less than what is normally observed using nuclear medicine imaging agents.

121 HYPR-LR processing holds great potential in nuclear medicine imaging for all applications with low S

122 nventional imaging procedure is CT; however, nuclear medicine imaging has also had a prominent role.

123 omboemboli using radiolabeled antibodies and nuclear medicine imaging have been disappointing.

124 rts to reduce radiation exposure from CT and nuclear medicine imaging in accord with the as-low-as-re

125 Various nuclear medicine imaging modalities are being used, incl

126 PA)-octreotide scintigraphy is currently the nuclear medicine imaging modality of choice for identify

127 in the activity administered for diagnostic nuclear medicine imaging of children.

128 ear medicine studies (six patients underwent nuclear medicine imaging once and one patient underwent

129 Nuclear medicine imaging showed increased activity consi

130 r SISCOM and (18)F-FDG PET results together, nuclear medicine imaging techniques showed coinciding vi

131 While traditionally nuclear medicine imaging techniques, in particular posit

132 icine imaging once and one patient underwent nuclear medicine imaging twice), and three magnetic reso

133 Conventional nuclear medicine imaging with large radiolabeled molecul

134 offers advantages for pediatric sedation for nuclear medicine imaging.

135 Since the official inception of nuclear medicine in 1971, the practice of nuclear medici

136 North American guidelines on the practice of nuclear medicine in children at 13 dedicated pediatric i

137 Nuclear medicine in the United States has grown because

138 k diagnostic imaging, radiation therapy, and nuclear medicine in unique ways by way of basic biology.

139 dicated network, SFMN-net [French Society of Nuclear Medicine]) in the scoring of uptake intensity (5

140 Imaging methods such as nuclear medicine (including positron emission tomography

141 Yet, there are concerns about the future of nuclear medicine, including progressively declining reim

142 quality-control (QC) procedures for current nuclear medicine instrumentation, including the survey m

143 Yens modified cloud chamber was the birth of nuclear medicine instrumentation.

144 m)Tc for single-photon imaging in diagnostic nuclear medicine is crucial, and current availability is

145 n prospective clinical trials in theranostic nuclear medicine is essential.

146 for greater accuracy, radiation dosimetry in nuclear medicine is evolving from population- and organ-

147 astly, radiation dose reduction in pediatric nuclear medicine is explicated.

148 Nuclear medicine is gradually evolving into molecular im

149 ication of advances in biomedical science to nuclear medicine is the concept of molecular targeting:

150 A potential milestone in personalized nuclear medicine is theranostics of metastatic castratio

151 The value of pediatric nuclear medicine is well established.

152 This article reviews the use of nuclear medicine, magnetic resonance, and optic imaging

153 als and techniques, including polarographic, nuclear medicine, magnetic resonance, and optical approa

154 was sent electronically to 13,221 Society of Nuclear Medicine members and radiation oncologists throu

155 m of this article is to review novel MRI and nuclear medicine methods for detecting and planning salv

156 tor studies (this publication will not cover nuclear medicine methods) are not routinely used.

157 possible to visually assess IDDS systems by nuclear medicine methods.

158 eing noncurative, the application of MRI and nuclear medicine modalities can help to identify patient

159 functional imaging that included at least 2 nuclear medicine modalities: (18)F-DA PET, (123)I-MIBG s

160 (n = 425), computed tomography (n = 89), and nuclear medicine (n = 11) examinations after rectal admi

161 = 90), magnetic resonance imaging (n = 108), nuclear medicine (n = 99), positron emission tomography

162 radiology (n=215), mammography (n=221), and nuclear medicine (n=249).

163 Although the multidisciplinary nature of nuclear medicine (NM) and clinical molecular imaging is

164 The practice of nuclear medicine (NM) in the Latin American and Caribbea

165 estimate the risk of cataract in a cohort of nuclear medicine (NM) radiologic technologists on the ba

166 or residents, fellows, and other trainees in nuclear medicine, nuclear cardiology, and radiology.

167 Eighty-two hospitals (67.8%) performed nuclear medicine on children.

168 uted tomography, magnetic resonance imaging, nuclear medicine) ordered by 164 primary care and 379 me

169 Counseling of nuclear medicine patients who may be concerned about exp

170 In many nuclear medicine patients, the activity distribution is

171 ide and integrated images was performed by a nuclear medicine physician and a radiologist.

172 operatively evaluated by a radiologist and a nuclear medicine physician and prospectively documented.

173 tained and visually graded by an experienced nuclear medicine physician as to the presence of classic

174 wo teams composed of one radiologist and one nuclear medicine physician each, read all 134 studies.

175 ologist, experienced in CT colonography, and nuclear medicine physician in consensus analyzed the dat

176 Two radiologists and a nuclear medicine physician in consensus evaluated the fo

177 2 radiology residents and 1 board-certified nuclear medicine physician independently and then in con

178 One nuclear medicine physician reviewed the PET/CT scans.

179 Clinical assessment was also performed by a nuclear medicine physician to determine amyloid status b

180 c accuracy by an experienced radiologist and nuclear medicine physician were performed.

181 An experienced nuclear medicine physician without knowledge of other te

182 Interpretation by the primary nuclear medicine physician, who had access to all clinic

183 ration by a dedicated medical oncologist and nuclear medicine physician.

184 Staging results were also compared by one nuclear medicine physician.

185 )Ga-PSMA-11 PET/CT images were analyzed by a nuclear medicine physician.

186 us and heterogeneous lesions as defined by 2 nuclear medicine physicians (P < 0.05).

187 Three nuclear medicine physicians and 6 medical physicists par

188 increased efficiency in scheduling, both for nuclear medicine physicians and for the operating room,

189 he PET and CT images were interpreted by two nuclear medicine physicians and one radiologist, respect

190 Nuclear medicine physicians and radiologists will need m

191 Two nuclear medicine physicians blinded to the patients' med

192 n of TOF and non-TOF images performed by two nuclear medicine physicians confirmed the advantages of

193 erformed by 1 chest radiologist for CT and 2 nuclear medicine physicians for PET.

194 The images were evaluated by 2 experienced nuclear medicine physicians in consensus, both qualitati

195 Images were reviewed by 2 nuclear medicine physicians in consensus, with the prese

196 This study provides guidance for nuclear medicine physicians in interpreting texture indi

197 Four nuclear medicine physicians independently reviewed the o

198 Nuclear medicine physicians must work to minimize false-

199 Three experienced nuclear medicine physicians then scored each striatum as

200 Nuclear medicine physicians therefore need to better und

201 hip prostheses were scored by 2 experienced nuclear medicine physicians to analyze clinical relevanc

202 CT scans were prospectively reevaluated by 3 nuclear medicine physicians using a structured scoring s

203 nterpretation, an expert panel of 3 external nuclear medicine physicians visually scored baseline and

204 ked and unmasked readings of the images by 2 nuclear medicine physicians were compared with the patho

205 more commonly early career radiologists, and nuclear medicine physicians were later career radiologis

206 Images were assessed by 5 nuclear medicine physicians who had limited prior experi

207 PET images were first reviewed by nuclear medicine physicians who had no clinical informat

208 erpretation was performed independently by 2 nuclear medicine physicians who were not aware of the cl

209 The studies were interpreted by 2 nuclear medicine physicians who were unaware of the labo

210 cle provides both investigative and clinical nuclear medicine physicians with a better understanding

211 In addition, this article provides nuclear medicine physicians with the background knowledg

212 preablation radioiodine imaging and provides nuclear medicine physicians with the background knowledg

213 age interpretation (based on the median of 3 nuclear medicine physicians' ratings) and semiautomated

214 PET/CT studies were interpreted by 2 nuclear medicine physicians, and discrepancies were reso

215 All studies were reviewed independently by 3 nuclear medicine physicians, and the results were then c

216 Two nuclear medicine physicians, blinded to the patient data

217 PET/CT studies were interpreted by 3 nuclear medicine physicians, independently.

218 oncologists, pathologists, radiologists, and nuclear medicine physicians, representing major internat

219 tapir scans (majority interpretation of five nuclear medicine physicians, who classified each scan as

220 tly interpreted by teams of radiologists and nuclear medicine physicians.

221 artition modeling was planned by experienced nuclear medicine physicians.

222 PET images were interpreted by two pediatric nuclear medicine physicians.

223 The images were read by 5 nuclear medicine physicians.

224 visually scored (3-level scale [Hvisu]) by 2 nuclear medicine physicians.

225 Three dual-accredited nuclear medicine physicians/radiologists identified the

226 In the early years of nuclear medicine, physicians explored applied nuclear ph

227 n observer study was performed with 5 expert nuclear medicine physicists.

228 into clinical practice and expands the role nuclear medicine plays in the care of patients with canc

229 s have had a substantial impact on pediatric nuclear medicine practice in the United States.

230 view first will cover the general aspects of nuclear medicine practice with these patients, including

231 NHL mAbs, RIT promises to become integral to nuclear medicine practice.

232 re cost-effectiveness data and evidence that nuclear medicine procedures affect patients' outcomes.

233 red about the administered activities for 16 nuclear medicine procedures commonly performed on childr

234 Patients undergoing nuclear medicine procedures for cancer therapy are admin

235 he radiation dose received by the fetus from nuclear medicine procedures is important because of the

236 radiologic procedures and about one-half of nuclear medicine procedures performed worldwide.

237 Average effective dose for most nuclear medicine procedures varies between 0.3 and 20 mS

238 m radiologic procedures and organ doses from nuclear medicine procedures, along with Biologic Effects

239 lation of effective doses for radiologic and nuclear medicine procedures.

240 ides that are used during routine diagnostic nuclear medicine procedures.

241 induced stochastic effects to patients after nuclear medicine procedures; and to discuss the need to

242 ddress terrorism, and the potential roles of nuclear medicine professionals in preparing for and resp

243 A nuclear medicine radiologist (blinded to correlative and

244 ng collaboration between radiation oncology, nuclear medicine/radiology, and medical physics teams is

245 egrated structure-function imaging, clinical nuclear medicine reaches beyond traditional specialty bo

246 Only 38% (330 of 867) of SRs on radiology or nuclear medicine-related imaging published from January

247 Nuclear medicine renal studies can be performed using sl

248 In 30 children, a nuclear medicine renogram was also obtained, and the hal

249 ure data can be extracted from institutional nuclear medicine report archives with high recall and pr

250 ing, manual validation was performed on 2359 nuclear medicine reports randomly selected from Septembe

251 maceuticals and administered activities from nuclear medicine reports was developed.

252 ensus by both an experienced CT reader and a nuclear medicine resident less experienced in CT.

253 The sestamibi nuclear medicine scan has become the best tool available

254 id is used, a preoperative lymphoscintigram (nuclear medicine scan) is often obtained to ease SLN ide

255 ion such as d-dimer testing, options include nuclear medicine scanning, catheter pulmonary angiograph

256 ard anteroposterior and lateral radiography, nuclear medicine scanning, MR imaging, and CT.

257 re performed for clinical indications by our nuclear medicine service from June 2001 through Septembe

258 olecular Imaging and the American College of Nuclear Medicine should choose the membership of a radio

259 ceuticals that were submitted to the British Nuclear Medicine Society (BNMS) online database (Radioph

260 as created by one senior radiologist and one nuclear medicine specialist by using all available CT an

261 Similarly, radiologists and nuclear medicine specialists should be sensitized to the

262 In addition, radiologists, nuclear medicine specialists, and radiation oncologists

263 atients underwent arteriography once), eight nuclear medicine studies (six patients underwent nuclear

264 ies in the viability of ischemic myocardium, nuclear medicine studies and stress echocardiography hav

265 In these young children, nuclear medicine studies are more likely to be used to e

266 The review then will discuss the specific nuclear medicine studies that typically are obtained in

267 ht patients referred in the usual manner for nuclear medicine studies underwent ERNA followed by GBPS

268 There were no image intensifiers, nuclear medicine studies, ultrasonography, computed tomo

269 patients can benefit from the full range of nuclear medicine studies.

270 ll calcification; gas; radiotracer uptake on nuclear medicine studies; and periaortic and associated

271 lymphomas, largely replacing gallium as the nuclear medicine study of choice.

272 This supplement to The Journal of Nuclear Medicine summarizes the presentations and discus

273 ssing the diagnostic and prognostic value of nuclear medicine techniques and, briefly, the methodolog

274 ng-free alternative to techniques like CT or nuclear medicine techniques for the evaluation of lung f

275 Imaging with nuclear medicine techniques plays an important role in d

276 Nuclear medicine techniques with application of oncophil

277 contrast to computed tomography (CT) and the nuclear medicine techniques, magnetic resonance imaging

278 ty-of-life issues for patients examined with nuclear medicine techniques.

279 nuclear physicians, affiliated researchers, nuclear medicine technologists, and radiation oncologist

280 ose associated with other commonly performed nuclear medicine tests, and the potential radiation risk

281 ose associated with other commonly performed nuclear medicine tests.

282 In nuclear medicine, the term theranostics describes the co

283 sewhere in this supplement to The Journal of Nuclear Medicine-the management of prostate cancer acros

284 In nuclear medicine, this expression describes the use of t

285 radiochemistry is an essential component of nuclear medicine; this includes imaging techniques such

286 What will be important is for nuclear medicine to be positioned as the quintessential

287 t is incumbent on practitioners of pediatric nuclear medicine to have an understanding of dosimetry a

288 ve been made for the European Association of Nuclear Medicine to restore its surveys of reported adve

289 e training after 2 clinical years, to 2 y of nuclear medicine training after 1 clinical year and, mos

290 clinical year and, most recently, to 3 y of nuclear medicine training after 1 clinical year.

291 nstructured experience before 1971 to 2 y of nuclear medicine training after 2 clinical years, to 2 y

292 Nuclear Medicine convened the Task Force on Nuclear Medicine Training to define the issues and devel

293 tment from 1965 to 2013 at the Department of Nuclear Medicine, University Hospital of Munster, Munste

294 Although nuclear medicine use decreased from 32 to 21 per 1000 en

295 Nuclear medicine uses ionizing radiation for both in viv

296 Thus, nuclear medicine views itself as being at a critical cro

297 d decade of the 21(st) century, a new era in nuclear medicine was initiated by the clinical introduct

298 ar for CT, US, interventional radiology, and nuclear medicine, while that for radiography increased 1

299 shift for the specialty but will ensure that nuclear medicine will be a major part of medical practic

300 n medical imaging and for the integration of nuclear medicine with primary care specialties to be dri